Skip to main content
. 2020 Mar 4;11(10):2921–2934. doi: 10.7150/jca.41834

Table 4.

Joint-effects survival analysis

Group Patients (n=500) MST (days) Crude P Crude HR (95% CI) Adjusted P* Adjusted HR* (95% CI)
I 219 1632 0.004 Ref. 0.039 Ref.
II 62 1492 0.050 1.582(1.000-2.503) 0.064 1.799(0.966-3.351)
III 219 1171 0.001 1.698(1.232-2.341) 0.017 1.732(1.102-2.722)

Notes: *adjustment for radiation therapy history; targeted therapy history; neoplasm status; TNM stage and residual tumors. Abbreviations: MST, median survival time; HR, hazard ratio; CI, confidence interval.